Monitoring for Extra-Intestinal Cancers in IBD
Abstract
Multiple studies have demonstrated an increased risk for extra-intestinal cancers in inflammatory bowel disease (IBD) patients, mainly from treatment modalities. Prominent cancers that are related to IBD treatment include the following: lymphoproliferative disorders associated with thiopurine use, hepatosplenic T cell lymphoma primarily in younger male patients on thiopurines and anti-tumor necrosis factor (TNF) agents, non-melanoma skin cancers in patients treated with thiopurines and anti-TNF agents, and melanomas in patients who are on monotherapy with anti-TNF agents. In addition, women with IBD may have higher rates of cervical dysplasia and cervical cancer. The focus of this review is to provide a comprehensive overview on extra-intestinal cancers in IBD patients and how to monitor for these malignancies.
Source: Current Gastroenterology Reports - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Gastroenterology | Inflammatory Bowel Disease | Lymphoma | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer | Study | T-cell Lymphoma | Women